Amgen drug sales boost bottom line | Pacific Coast Business Times

You are here: Home > Central Coast Health Watch > Current Article

Drug sales for biotech giant Amgen boost bottom line

By Alex Kacik / Friday, February 10th, 2017 / Comments Off on Drug sales for biotech giant Amgen boost bottom line

Proposals to streamline regulatory approval of new drugs would bode well for biotech companies like Amgen in Thousand Oaks. Thousand Oaks-based Amgen reported revenue of $6 billion in the fourth quarter of 2016, besting analyst estimates of $5.74 billion and increasing more than 7 percent from the fourth quarter of 2015. The world’s largest biotech…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.